Containing and Enhancing Potent Particles with Micronization

Published on: 

A multilayered processing approach ensures safe handling and content uniformity of highly potent APIs.

Micronization is an important tool for developing new drugs, its primary advantage being that it is scalable from the early stages of development through to commercial volumes. The micronization process is both well-understood and cost-effective.

With the increased number of potent drugs in development, having the capabilities to handle and process them is becoming imperative. Development partners with the specialized expertise and infrastructure required to handle potent APIs play a key role in the supply chain of next generation medicines.

Read this article in Pharmaceutical Technology’s October 2021 APIs, Excipients, and Manufacturing eBook.


About the Author

Andy Maitland is operations and supply chain director, Catalent.

Article Details

Pharmaceutical Technology
eBook: APIs, Excipients, and Manufacturing
October 2021
Pages: 30–35


When referring to this article, please cite it as A. Maitland, “Containing and Enhancing Potent Particles with Micronization,” Pharmaceutical Technology APIs, Excipients, and Manufacturing eBook (October 2021).